Advertisements

Аллегра

Quick links to important sections

Аллегра

Selected form

Advertisements
Advertisements

Treatment option: Rhinitis, Hay Fever

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Аллегра

Property Description
Active ingredient Фексофенадин (Fexofenadine hydrochloride)
Form Oral Tablet, Oral Suspension, Orally Disintegrating Tablet (ODT)
Pharmacological class Second-generation H1-receptor antagonist
Common use Symptomatic relief of allergic reactions
Origin Synthetic compound

Аллегра: Drug Type and Pharmacological Classification

Аллегра is the trade name for a highly selective synthetic medicine whose active ingredient is Фексофенадин (Fexofenadine), usually administered as Fexofenadine hydrochloride. This substance is classified as a second-generation H1-receptor antagonist, which is a specific class of Antihistamine used to counteract the effects of histamine in the body. Fexofenadine is notable because it is the major active metabolite of the older antihistamine, terfenadine, a modification that was clinically recognized for enhancing the drug’s safety profile by bypassing certain metabolic pathways. Fexofenadine effectively blocks histamine receptors to prevent allergic responses, helping to interrupt the body's allergic cascade.

Composition, Forms, and General Purpose

The composition is centered around Fexofenadine hydrochloride, which is typically presented as a single-ingredient product, although formulations combined with a decongestant also exist. The medication is designated for the oral route of administration and is available in multiple common dosage forms, including the Oral Tablet, an Oral Suspension (Liquid) for pediatric or ease-of-swallowing patient groups, and an Orally Disintegrating Tablet (ODT). The general purpose of this second-generation antihistamine is to alleviate the physical symptoms that arise from the body’s exaggerated response to common allergens, such as providing relief from sneezing and watery eyes during seasonal changes.

Unique Action: The Non-Sedating Characteristic

Fexofenadine is widely recognized as a non-sedating antihistamine because its molecular structure is designed to exhibit selective peripheral H1-receptor antagonist activity. This selectivity means the drug works mainly on receptors located outside the central nervous system, with minimal ability to cross the blood-brain barrier. This focused mechanism provides the practical benefit of effective symptomatic relief while substantially minimizing the risk of drowsiness, a common effect associated with first-generation antihistamine agents, a difference that is fundamental to its contemporary positioning in allergy management.

Regulatory References

  1. NIH MedlinePlus
Advertisements

What side effects are possible with Аллегра?

Official Classification of Possible Side Effects

The safety profile of Fexofenadine, the active ingredient in Allegra, is classified by regulatory authorities (such as the FDA and EMA) based on incidence observed in clinical trials and post-marketing surveillance. Adverse reactions are grouped by System-Organ Class to delineate effects across different physiological systems.

Common Adverse Reactions

The most frequently reported side effects, officially classified as common, typically include effects such as headache, drowsiness (somnolence), dizziness, and nausea.

Serious and Post-Marketing Reactions

Adverse reactions that are rare or have been reported primarily through post-marketing surveillance are officially classified with a frequency not known. These include reactions related to the Immune System, specifically severe hypersensitivity reactions such as angioedema (swelling of the face, lips, or throat), systemic anaphylaxis, and urticaria (hives). Reactions affecting the Cardiac System, such as palpitations and tachycardia (rapid heartbeat), have also been documented in official reports.

Safety Considerations for Special Populations and Administration

Regulatory documentation includes specific safety statements for certain groups. Caution is advised for patients with renal impairment, as decreased kidney function can lead to increased systemic exposure to Fexofenadine. Older adults may also require particular attention due to a higher likelihood of age-related declines in kidney function. Additionally, the absorption and systemic exposure of Fexofenadine may be reduced when taken with antacids containing aluminum or magnesium hydroxide, and when ingested with certain fruit juices.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help — Fexofenadine Hydrochloride

The official regulatory profile for Fexofenadine hydrochloride (Allegra) is structured around documented symptomatic manifestations and regulator-mandated emergency actions.

Documented Overdose Presentation Management and Constraints
Documented manifestations Symptoms noted in regulatory labeling following overdose include dizziness, drowsiness (somnolence), fatigue, and dry mouth.
Dose-related factors Doses up to 800 mg in single exposures and 690 mg twice daily have been administered to healthy volunteers without resulting in clinically significant adverse events compared to placebo. The maximum tolerated dose is not established.
Procedural constraint Haemodialysis is explicitly documented as not effective for removing Fexofenadine from the bloodstream.

Required Emergency Actions and Treatment

Regulatory Mandate Treatment Approach
Immediate action required Regulatory guidance mandates that individuals seek immediate medical attention or contact a Poison Control Center right away when an overdose is suspected.
Treatment measures Management is focused on symptomatic and supportive treatment. Healthcare professionals should consider standard measures to remove any unabsorbed medicinal product. No specific antidote is documented in the official prescribing information.

The official guidance emphasizes that a suspected overdose is a medical event requiring immediate contact with a healthcare professional, even if the documented symptoms are non-severe. Management protocols are focused entirely on supportive care and the elimination of unabsorbed substance.

Advertisements

Therapeutic Uses of Аллегра

What Allegra Treats — Main Uses and Benefits

Allegra is commonly used to help manage symptoms associated with both seasonal allergic rhinitis (often called hay fever) and chronic idiopathic urticaria (long-term hives). This medication is applicable within clinical settings that involve acute or disruptive symptom patterns and is relevant for easing certain distressing symptoms across these therapeutic domains.

It is used to help address symptom clusters that may become intense or disruptive, including sneezing, runny nose, itchy or watery eyes, itching of the nose or throat, and generalized skin itching with hives. It is often applied during phases when symptoms become more noticeable, offering supportive relief that helps patients cope more steadily.

Support for Chronic Skin Hives (Urticaria)

This medication is relevant for easing the symptom load of allergic manifestations in the eyes, nose, and skin, supporting comfort during flare-ups. This supportive therapeutic approach helps ease the overall symptom load and supports general well-being during periods of heightened symptoms.


Quick Fact: Relief for Itching and Sneezing This medicine is commonly used when short-term symptomatic assistance is needed to address both upper respiratory discomfort and skin irritation.

Regulatory References

  1. DailyMed NIH Label for Fexofenadine
Advertisements

Eligibility and Restrictions for Use

Eligibility for Fexofenadine (Allegra)

The use of Fexofenadine is strictly determined by official regulatory criteria focusing on age, known allergies, organ function, and physiological state.

Absolute Contraindication

Classification Population Status
Hypersensitivity Patients with a known allergy to Fexofenadine or any excipients Contraindicated

Age-Group Eligibility

The eligibility based on age varies by drug formulation. Tablets are generally approved for use in individuals 12 years of age and older. Oral suspension/liquid forms allow use in children as young as 6 months for specific approved conditions. Use in infants under 6 months of age has not been established by regulatory documents.

Conditional Use and Restrictions

  • Impaired Renal Function (Kidney Disease): Use requires caution and a dose adjustment is recommended due to altered drug elimination.
  • Pregnancy and Lactation: Use during pregnancy and breastfeeding is not recommended unless considered clearly necessary, based on official regulatory status.
  • Cardiovascular Risk: Caution is advised in older patients and those with a history of cardiovascular disease.
Advertisements

What should I know about interactions with other medicines?

Allegra Interactions with other Medicines and Products

Interactions with fexofenadine (Allegra) are primarily related to effects on drug transporters, which alter the plasma concentration and total exposure of the medicine. The official regulatory profile establishes specific constraints regarding co-administration with certain medications and food products.


Documented Pharmacokinetic Interactions

Co-administration with the P-glycoprotein inhibitors Erythromycin or Ketoconazole is documented to significantly increase fexofenadine's systemic exposure ( AUC and Cmax). This occurs because these substances enhance the medicine's absorption and decrease its elimination.

Conversely, antacids containing Aluminum and Magnesium hydroxide substantially reduce fexofenadine exposure when taken closely in time. This requires separation of administration to avoid a marked reduction in bioavailability.


Administration Restrictions

Interaction Type Interacting Substance Regulatory Constraint
Drug-Food Fruit Juices (Grapefruit, Apple, Orange) Administration of fexofenadine must be with water only to prevent the OATP transporter-related reduction in absorption.
Timing-Based Antacids (Aluminum/Magnesium) Should not be taken closely in time with fexofenadine to maintain adequate absorption.

Population-Specific Caution

In patients with renal impairment, fexofenadine clearance is documented as slower. This results in a prolonged half-life and elevated plasma levels of the medicine, which is a condition noted in regulatory information.

Advertisements

Mechanism of Action

H1 Receptor Blockade and Downstream Modulation

The mechanism of action is centered on the active component, fexofenadine, which functions as a selective antagonist of the Histamine H1 receptors on peripheral cells. By binding to these receptors, the drug stabilizes them in an inactive conformation, thereby preventing the endogenous mediator histamine from initiating its normal signaling cascade. This action interrupts the histaminergic pathway, suppressing the cellular response that typically follows receptor activation.


Physiological Consequence and Activity Constraint

Disrupting the H1 signaling modifies the downstream physiological cascade by limiting the resulting increase in vascular permeability and subsequent fluid extravasation from small blood vessels in peripheral tissues. Furthermore, the drug is predominantly restricted to acting in the body's periphery. Due to its physicochemical properties and affinity for P-glycoprotein transporters, CNS penetration is significantly limited. This constraint results in a mechanism that operates primarily within peripheral systems, which limits the compound's influence on central histaminergic pathways.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Аллегра (Fexofenadine)

The use of Fexofenadine is restricted to the oral route of administration in approved forms, including tablets, oral suspension, and orally disintegrating tablets (ODT). The official guidelines for administration specify dose schedules and contextual intake instructions, which are followed to ensure proper use within the established framework for use.

Instruction Detail
Standard Adult Dose (Ages 12 and older) 180 mg once daily, or 60 mg twice daily. The maximum daily dose is 180 mg.
Pediatric Dosing Ages 6 to 11 years: 30 mg twice daily. Ages 6 months to <2 years: 15 mg twice daily (suspension only).
Renal Impairment Adjustment For adults and children with reduced kidney function, the starting dose is halved, typically administered once daily (e.g., 60 mg once daily for adults).
Administration Context Tablets and suspension are taken with water. Intake is not concurrent with grapefruit, apple, or orange juices, as these can significantly reduce drug absorption.
Special Handling Simultaneous administration with aluminum or magnesium-containing antacids is avoided. The oral suspension is to be shaken well before measuring the dose. The ODT form is to be dissolved on the tongue and taken on an empty stomach.

The dosage schedule is based on a daily frequency, either once or twice daily, which supports long-acting, symptomatic management. These administration constraints and specific dose adjustments define the standard use protocol for Fexofenadine.

Advertisements

Recent Clinical Evidence

Аллегра: Recent Clinical Evidence

Recent research focusing on fexofenadine (the active substance in Allegra) has continued to evaluate its profile in treating allergic conditions, primarily seasonal allergic rhinitis (SAR) and chronic idiopathic urticaria (CIU).


Efficacy in Seasonal Allergic Rhinitis (SAR)

Clinical trials, including randomized, double-blind, placebo-controlled studies, have demonstrated that the compound may affect total symptom scores (TSS) in adults and children with SAR. Primary outcomes frequently examined the reduction of both reflective and instantaneous TSS, covering symptoms like sneezing, runny nose, itchy nose/palate, and itchy/watery eyes, usually after dosing periods of two weeks. A meta-analysis of multiple randomized controlled trials found a significant change from baseline in TSS compared to placebo.

Newer research has also investigated the compound's effect on SAR symptoms that are aggravated by air pollutants, such as diesel exhaust particles. A phase 3 study conducted in an environmental exposure unit reported that fexofenadine 180 mg was associated with changes in Total Nasal Symptom Scores in this specific context.


Evidence for Chronic Urticaria (CIU)

Studies have assessed the compound's use in CIU, often evaluating changes in the mean pruritus score (MPS) and the mean number of wheals (MNW) over a four-week period. These studies reported that different doses of fexofenadine were associated with a statistically significant reduction in CIU signs and symptoms compared to placebo.

Research has also explored the use of up-dosing (increasing the standard licensed dose) in patients whose CIU symptoms are not controlled by the conventional dose. Evidence suggests that increasing the dose to three or four times the standard amount may lead to further symptom control in specific non-responsive patient populations.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Аллегра (FAQ)


Q: Does Аллегра make you sleepy or drowsy?

Fexofenadine is classified by official sources as a second-generation antihistamine, which means it is generally associated with minimal sedation. The minimal potential for sedation is attributed to the drug’s properties, as described in authoritative medical sources. However, it is important to note that clinical trials have included reports of drowsiness and fatigue as possible side effects.


Q: How quickly does Аллегра start working?

According to official product information, the initial antihistamine effects can generally be detected within one hour after taking the medication. The maximum therapeutic effect, which is the point where the drug is working most strongly, is typically reached about 2 to 3 hours after ingestion.


Q: Can you take Аллегра every day for a long time?

Fexofenadine is a long-acting antihistamine that is indicated for the daily, symptomatic management of conditions like seasonal allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives). Clinical studies have examined its administration for up to 12 months for these indicated conditions. Patients considering chronic administration should rely on professional guidance.


Q: Do you need a prescription for Аллегра?

Fexofenadine is widely available in many countries as an over-the-counter (OTC) medicine, meaning a prescription is not required to purchase it. However, some specific dosage strengths or combination products that include fexofenadine may still require a prescription.


Q: What happens if I forget to take a dose of Аллегра?

According to patient information guidelines, if a scheduled dose is missed, it is generally advised to take it as soon as it is remembered. However, patient information generally indicates that if it is almost time for the next scheduled dose, the missed dose is usually not taken to avoid a double dose.


Q: Does Аллегра interact with blood pressure medicine?

Official regulatory documents describe potential interactions with certain transport proteins. While specific classes like blood pressure medications are not always listed individually, Regulatory documents emphasize the importance of awareness regarding all co-administered medications to identify potential interactions.


Q: Why do some people say Аллегра doesn't make them tired?

The reason is related to its classification as a second-generation antihistamine, which is associated with a lower potential for sedation. This category of medicines is noted in authoritative sources for having minimal influence on central nervous system function.


Q: Is it okay to take Аллегра during pregnancy?

Official guidelines recommend that fexofenadine should be used during pregnancy only if the potential benefit to the user is considered to justify the potential risk to the fetus. Regulatory information indicates that the determination of its use during pregnancy is a matter for professional clinical assessment.


Q: What is the duration of action for Аллегра?

The time it takes for the body to eliminate half of the drug (the elimination half-life) is approximately 11 to 15 hours. The drug's anti-allergic effects are generally sustained for up to 14 hours following administration, which supports the drug’s typical once or twice daily dosing schedule.


Q: Is Аллегра known to cause anxiety?

While nervousness and insomnia have been reported as side effects in official safety documents, anxiety is not typically listed as a common reaction. Patients are generally encouraged to report any new or worsening symptoms to a professional.


Q: Does Аллегра work for skin hives or rashes?

Yes, fexofenadine is formally indicated by official regulatory bodies for the treatment of uncomplicated chronic idiopathic urticaria (the medical term for long-term hives or welts on the skin) in addition to allergy symptoms.


Q: What is the difference between prescription and over-the-counter Аллегра?

The distinction often lies in the dosage strength of the active ingredient (fexofenadine) or if it is sold as a combination product containing a decongestant. The active ingredient itself is the same in both the prescription-only and OTC versions.


Q: What are the most common side effects reported for Аллегра?

Based on clinical trial data found in official patient information, the most frequently reported side effects include headache, a feeling of drowsiness, dizziness, and nausea.


Q: Is Аллегра considered a 'non-drowsy' allergy medicine?

Yes, fexofenadine is widely recognized and categorized in regulatory and patient-facing materials as a non-sedating or 'non-drowsy' antihistamine. This classification is given because it has a low tendency to cause sleepiness compared to older allergy medicines.


Q: Can you take Аллегра and Benadryl at the same time?

Official drug interaction information generally advises caution against combining fexofenadine with other antihistamines, particularly first-generation types like diphenhydramine (Benadryl). This combination may increase the likelihood or intensity of side effects, such as sedation.


Q: Is Аллегра safe to take while breastfeeding?

The use of fexofenadine while nursing requires careful consideration. Official sources state that the medicine should only be used if a healthcare provider determines that the potential benefit outweighs any potential risk to the nursing infant. Regulatory guidance indicates that the use of fexofenadine while nursing requires an assessment by a professional to weigh the potential benefit against the potential risk to the infant.


Q: Does Аллегра interact with alcohol?

Yes, patient safety guidance advises that the risk of experiencing adverse effects like drowsiness or dizziness may be increased if alcohol is consumed while taking fexofenadine. Official guidance describes a need for caution.


Q: What is the active form of fexofenadine?

Fexofenadine itself is the active metabolite of the historical drug terfenadine. This means fexofenadine is the form that carries out the anti-allergic action. It is minimally processed in the liver, with most of the medicine being eliminated from the body unchanged.


Q: Why is it important to check the expiration date of Аллегра?

As with all regulated medicines, it is critical to adhere to the expiration date provided by the manufacturer. Regulatory standards confirm that after this date, the potency, safety, and effectiveness of the drug are no longer guaranteed to meet the official standards.


Q: Does Аллегра cause dry mouth?

Fexofenadine is a second-generation antihistamine that is designed to have very low affinity for the receptors that cause side effects like dry mouth (anticholinergic effects). Therefore, dry mouth is less likely than with older antihistamines. Reported symptoms are generally documented for patient safety.


Q: Are there studies on Аллегра use in patients with liver disease?

Yes, pharmacokinetic studies are part of the regulatory approval process. These studies have generally indicated that the body's process of handling fexofenadine in patients with hepatic (liver) disease does not differ substantially from that of healthy individuals.


Q: Is it possible to become resistant to the effects of Аллегра?

Official research themes indicate that prolonged or continuous use of fexofenadine is not known to cause tachyphylaxis. This is the medical term for when the body rapidly adapts to a drug, leading to a noticeable decrease in its effectiveness over time.


Q: Does Аллегра come in a liquid form for children?

Yes, the manufacturer produces fexofenadine in an oral suspension (liquid) form. This dosage form is typically intended for use in pediatric patients who may have difficulty swallowing tablets.


Q: Can Аллегра cause stomach upset or nausea?

Yes, according to safety data from clinical trials, gastrointestinal effects are possible. Nausea and occasional stomach upset or vomiting have been reported as common side effects of fexofenadine.


Q: What are the rare but serious side effects of Аллегра?

Rarely, fexofenadine has been associated with severe hypersensitivity reactions. These can include angioedema (swelling of the face, throat, or tongue) or systemic anaphylaxis. Official safety instructions state that severe reactions are medical emergencies.


Q: Is Аллегра effective for indoor dust allergies?

Fexofenadine is officially indicated for Seasonal Allergic Rhinitis, which addresses symptoms caused by common airborne allergens. While not specifying dust, the treatment scope applies broadly to allergic symptoms like sneezing and runny nose caused by environmental triggers.


Q: What is the typical time frame for stopping Аллегра before an allergy skin test?

Clinical guidelines often recommend discontinuing antihistamines like fexofenadine for a specific period before allergy skin testing. The typical time frame advised is 24 to 48 hours to ensure the drug does not interfere with the reliability of the test results.


Q: Can Аллегра be taken with other cold medicines?

Patients should be cautious when combining fexofenadine with over-the-counter cold medicines. Patients are generally encouraged to check the ingredients of combination cold medicines to identify possible overlap or interaction components.


Q: Does Аллегра help with eye itching and watering?

Yes, official regulatory indications state that fexofenadine is approved for the relief of the typical symptoms associated with seasonal allergic rhinitis. This symptom relief includes the reduction of itchy eyes and watery eyes.


Q: What does 'seasonal allergic rhinitis' mean in the context of Аллегра?

Seasonal allergic rhinitis is the medical term for the allergic reaction that causes symptoms like sneezing, runny nose, and itching during specific times of the year. This condition, which is often called hay fever, is the primary indication for which fexofenadine is approved.


Q: Are there any special instructions for storing Аллегра tablets?

Official quality standards require fexofenadine to be kept in a well-closed container and stored at a controlled room temperature. It should be protected from exposure to excessive heat, moisture, and freezing temperatures to maintain its stability and effectiveness.


Q: Is the evidence for Аллегра based on large clinical trials?

Official documents and authoritative medical sources refer to the data used for drug approval. The efficacy and safety data for fexofenadine are supported by results derived from controlled clinical trials that involved a significant number of participants.


Q: Why is Аллегра sometimes preferred over older allergy medicines?

Official literature often highlights that fexofenadine is a second-generation antihistamine noted for its low tendency to cause drowsiness. This difference in sedation profile is the key reason it is often noted in professional discourse over older (first-generation) allergy medicines.


Q: Are headaches a common side effect of Аллегра?

Yes, based on data published in the official patient information and safety documents, headache is one of the side effects that has been commonly reported by participants in clinical trials of fexofenadine.


Q: What should I do if I experience a serious reaction after taking Аллегра?

If symptoms of a serious allergic reaction occur—such as sudden difficulty breathing, swelling of the face, lips, or tongue, or signs of throat closure—official safety instructions indicate that in the event of severe symptoms—such as swelling or breathing issues—it is a medical emergency.


Q: Can Аллегра be used to prevent allergy symptoms?

Fexofenadine is generally described in official sources as being used for the symptomatic control of allergic conditions. As a long-acting treatment, it is intended for regular, daily use to manage and suppress symptoms as they arise.


Q: What research shows about the long-term safety of Аллегра?

Official literature and evidence support that fexofenadine can be used over extended periods. Studies have shown no concerning safety signals or unexpected increases in side effect frequency, supporting its use for long-term symptom management.


Q: Can children take Аллегра?

Yes, fexofenadine is approved for use in pediatric patients for certain indications. The official guidelines provide specific dosing instructions based on the child’s age, with approved use beginning for some conditions in infants as young as 6 months of age.


Q: Can older adults use Аллегра?

While the dosage is generally the same, older patients may experience changes in how the body processes the medication, particularly if they have reduced kidney function. Regulatory data indicates that use in older adults may require professional consideration due to potential changes in drug processing.


Q: Does taking more Аллегра than recommended make it work better?

Official product instructions specify a maximum recommended daily dose. Exceeding this dose is not recommended because it does not typically increase the therapeutic benefit and instead may increase the risk of experiencing adverse side effects.


Q: Is it true that fruit juice can affect how Аллегра works?

Yes, official labeling explicitly warns that taking fexofenadine with grapefruit, apple, or orange juices can significantly interfere with the body's ability to absorb the drug. This effect may reduce the overall effectiveness of the medication.


Q: Are there different strengths of Аллегра available?

Yes, fexofenadine is available in different strengths to accommodate various approved dosing regimens. Common strengths include 30 mg, 60 mg, and 180 mg tablets or capsules, as well as an oral suspension.


Q: Is fexofenadine (Аллегра) a first-generation or second-generation antihistamine?

Fexofenadine is classified in all authoritative and medical sources as a second-generation antihistamine. This category of medicines is generally characterized by being non-sedating, with a lower risk of anticholinergic side effects compared to older (first-generation) agents.

Advertisements

How should Аллегра be stored and disposed of?

Official Storage and Handling Requirements

Fexofenadine tablets, including the product Allegra, must be stored within a specific controlled room temperature range, typically between 20 C and 25 C (68 F and 77 F), with limited excursions permitted. To maintain product stability, the medication must be stored in its original, tightly closed container and protected from excessive moisture and direct light. The product must be kept out of the reach of children and pets to prevent accidental ingestion, as mandated by regulatory bodies.

Disposal Instructions

To dispose of unused or outdated medication, patients are instructed to consult a pharmacist for guidance on proper drug take-back programs or safe disposal procedures. Official guidelines state that the product should not be discarded in wastewater or household trash, aligning with environmental protection and pharmaceutical waste protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Аллегра found in:

A-Z Index: